Risk factors for relapse in chronic hepatitis C patients who have achieved end of treatment response

E-ISSN： 1440-1746|25|5|957-963

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.25, Iss.5, 2010-05, pp. : 957-963

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cumulative incidence and risk factors for the development of hepatocellular carcinoma in patients with chronic hepatitis B who achieved sustained disappearance of viremia by nucleos(t)ide analog treatment

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E240-E251

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1183-1189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-04 ,pp. : 192-197

Karger

Access to resources Recommend Favorite

Treatment of Chronic Hepatitis C in Patients with End-Stage Renal Disease and Hemophilia – The Singapore Experience

Intervirology, Vol. 49, Iss. 1-2, 2005-09 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Influence of Pre-treatment Factors on Outcome of Interferon-alpha Treatment of Patients with Chronic Hepatitis C

By Weiland Ola Braconier Jean Henrik Frydén Aril Norkrans Gunnar Reichard Olle Uhnoo Ingrid

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 2, 1999-07 ,pp. : 115-118

Informa Healthcare

Access to resources Recommend Favorite